| Filed On | Filing |
|---|---|
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition
SALT LAKE CITY, UT, November 5, 2026 — Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today reported financial results for the ... |
| 14 Sep 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
Reller Joins Health Catalyst as it Enters Its Next Phase of Growth |
| 08 Sep 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
The name of the plan is the Health Catalyst, Inc. 2026 Employment Inducement Incentive Plan (the “Plan”). The purpose of the Plan is to encourage and enable employees of Health Catalyst, Inc. (the “Company”) and its Subsidiaries upon who... |
| 06 Aug 2026 |
8-K: Termination of a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +2 more
SALT LAKE CITY, UT, August 6, 2026 — Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today reported financial results for the qu... |
| 20 Jul 2026 |
8-K: Submission of Matters to a Vote of Security Holders
On July 16, 2026, Health Catalyst, Inc. (the “Company”) held its annual meeting of stockholders (the “Annual Meeting”). The Company’s stockholders voted on four proposals at the Annual Meeting, each of which is described in greater detai... |
| 04 Jun 2026 |
8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
SPECIFIC TERMS IN THIS AGREEMENT HAVE BEEN REDACTED BECAUSE SUCH TERMS ARE BOTH NOT MATERIAL AND ARE OF A TYPE THAT HEALTH CATALYST, INC. TREATS AS CONFIDENTIAL. THESE REDACTED TERMS HAVE BEEN MARKED IN THIS EXHIBIT AT THE APPROPRIATE PL... |
| 11 May 2026 |
8-K: Results of Operations and Financial Condition
SALT LAKE CITY, UT, May 11, 2026 — Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today reported financial results for the quar... |
| 30 Apr 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
Nelson Joins as the Company Builds the Leadership Infrastructure for Its Next Phase |
| 27 Apr 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Other Events
On April 24, 2026, the Board of Directors (our Board) of Health Catalyst, Inc. (the Company) determined that Linda Llewelyn will cease to serve as the Chief People Officer of the Company effective June 1, 2026 due to the elimination of t... |
| 03 Apr 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
This Transition Agreement (this “Agreement”) is entered into between Daniel Burton (“Executive”) and Health Catalyst, Inc. (the “Company”) (each a “Party” and together the “Parties”), as of the Effective Date (as defined in Section 1), w... |
| 12 Mar 2026 |
8-K: Results of Operations and Financial Condition
SALT LAKE CITY, UT, March 12, 2026 — Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ... |
| 18 Feb 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
We are pleased to extend to you this offer of employment with Health Catalyst (“HC” or the “Company”). We are confident that your skills, experience and hard work will contribute meaningfully to the success of the company. This offer is ... |
| 23 Jan 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On January 20, 2026, the Board of Directors of Health Catalyst, Inc. (the Company) determined that Kevin Freeman will cease to serve as the Chief Commercial Officer of the Company on February 1, 2026. In order to enable a smooth transiti... |
| 12 Jan 2026 |
8-K: Results of Operations and Financial Condition
© 2026 Health Catalyst Inc. All Rights Reserved. Select 2025 Preliminary Unaudited Results(1) and Key Themes Note: This summary contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amend... |
| 02 Dec 2025 |
8-K: Entry into a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation +1 more
For good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Health Catalyst, Inc., a Delaware corporation (the “Company”), and First Light Asset Management, LLC, a Delaware limited liability company... |
| 10 Nov 2025 |
8-K: Results of Operations and Financial Condition
SALT LAKE CITY, UT, November 10, 2025 — Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quart... |
| 10 Sep 2025 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
We are pleased to offer you a new position with Health Catalyst (“HC” or the “Company”). We are confident that your skills, experience and hard work will contribute meaningfully to the success of the company in this new role. This offer ... |
| 07 Aug 2025 |
8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation
SALT LAKE CITY, UT, August 7, 2025 — Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ... |
| 10 Jul 2025 |
8-K: Submission of Matters to a Vote of Security Holders
On July 9, 2025, Health Catalyst, Inc. (the “Company”) held its annual meeting of stockholders (the “Annual Meeting”). The Company’s stockholders voted on four proposals at the Annual Meeting, each of which is described in greater detail... |
| 07 May 2025 |
8-K: Results of Operations and Financial Condition
SALT LAKE CITY, UT, May 7, 2025 — Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter end... |
Loading...